Figure 3.
Effect of neonatal genistein exposure on glucocorticoid target gene expression in the adult uterus. (A) Schematic representation of dosing schedule, surgical intervention, and experimental end points. Body and uterine weight (g) was determined on PND56 for control and genistein-treated mice. Data represent mean of . (B and C) Relative mRNA expression of Ppib, Gilz, Fkbp5, Sgk1, Klf13, Per1, , and Il13ra2 as measured by qRT-PCR 4 h following intraperitoneal injection of vehicle or Dex in adult ADV/OVX mice on PND56. (B) Basal expression was determined by comparing the vehicle-treated genistein group to vehicle-treated control group. (C) Fold change was determined by reporting values relative to vehicle-treated controls. Values are normalized to the reference gene Ppib. (D) Per1, , and Il13ra2 mRNA expression was determined by reporting values relative to vehicle-treated controls. Bar graphs show the from 3 to 5 animals. * , ** as determined by ANOVA with Tukey’s post hoc analysis. ADX/OVX, adrenalectomized/ovariectomized; Dex, dexamethasone; PND, postnatal day; qRT-PCR, quantitative real-time polymerase chain reaction; Treat, treatment; Veh, vehicle.